Critical Care Solutions, Inc. develops advanced, multi-functional medical device patents. Our portfolio replaces standard single-use clinical plastics with integrated natural resin frameworks, securing high repeat margins, massive hospital cost cuts, and protected barriers to entry.
US Patents
Granted & Pending
$16.9B
2030 Global TAM
42%
Clinical Spend Saved
Conceptual | Adaptable Care | Transforming Systems
We are a group of healthcare professionals working on research and development of unique products.
Our VISION is to improve patient care and provide cost-effective solutions at the same time.
Our MISSION is to provide healthcare professionals with unique, cost-effective products to improve the quality of care.
Explore interactive metrics, clinical studies, and financial valuation statistics demonstrating the global scalability of our patented medical device IP.
Our Patented IP Product Range
Select any device to explore its high-resolution CAD details, slide specs, official patent status, and clinical bedside scenarios.
Optimizes the delivery of medical gases by efficiently managing distribution based on molecular weight. The lighter gases remain closer to the airway within the mask, while heavier gases settle at the bottom or near exit points to minimize carbon dioxide rebreathing.
A prospective multi-center crossover pilot study of 15 hypoxemic subjects evaluated standard HFNC versus HFNC with our Double-Trunk Mask design (TPM). The published findings demonstrate immediate, safe improvement in physiological arterial oxygenation.
Subject receiving classic high-flow nasal cannula (HFNC) therapy with a double-trunk mask (DTM). The DTM is composed of a normal aerosol mask (nebulizer and mouthpiece) with 2 lateral holes (22 mm in diameter) and 15 cm of corrugated tubing inserted in the holes.
Background: High-flow nasal cannula (HFNC) oxygen therapy is used to deliver an FiO2 from 0.21 to 1.0. The double-trunk mask (DTM) is designed to increase the FiO2 in patients with a high inspiratory flow demand already receiving HFNC.
Methods: A prospective multi-center crossover pilot study including 15 subjects treated with HFNC for acute hypoxemic respiratory failure. Measurements were performed at the end of 30-min periods with HFNC only, with HFNC + DTM, and again with HFNC only.
Conclusion: In subjects receiving oxygen via HFNC, the addition of the DTM over the HFNC increased PaO2 without changing the PaCO2.
Patient receiving classic high-flow nasal cannula (HFNC) therapy with a double-trunk mask (DTM). The DTM is composed of a normal aerosol mask (nebulizer and mouthpiece) with 2 lateral holes (22 mm in diameter) and 15 cm of corrugated tubing inserted in the holes.
This crossover study was completed by clinicians in ICU settings and officially published in the peer-reviewed journal Respiratory Care. It validates the physiological advantage of combining high-flow nasal cannula therapies with double-trunk structures to help prevent dilution from ambient room air entrainment.
Read direct clinical evaluations and recommendation feedback from board-certified pulmonologists, critical care physicians, and registered respiratory specialists who have evaluated our designs.
"Any clinician treating hospitalized patients deals with hypoxic respiratory failure daily. The SINODA device is a simple, elegant solution that allows for uninterrupted flow of oxygen while allowing simultaneous inhaled medication administration. Seamless compatibility with multiple oxygen interfaces makes it seemingly indispensable."
Board Certified Pulmonary & Critical Care Medicine
"I have witnessed first-hand the effectiveness of the SINODA adapter. This practical and simple device allows high concentration oxygen delivery and nebulized therapies simultaneously, in a safe and controlled manner. The versatility and simplicity make it an invaluable tool—the Swiss Army Knife of respiratory devices."
Pulmonary, Sleep & Critical Care Specialist
"The ability to deliver bronchodilators while supporting oxygenation and avoiding carbon dioxide retention is critical to treating patients with respiratory conditions and potentially avoids their deterioration and the need for ventilatory support. The adapter's clever design allows any of these therapies to be applied with neonatal, pediatric, or adult equipment."
Pulmonary & Critical Care Medicine Specialist
"Until now, combining treatments usually resulted in an undetermined amount of inspired oxygen being delivered, and was cumbersome and tedious. The SINODA design consists of a bifurcating adapter... In summary, the device is unique and versatile with a diverse range of potential applications, easy to use, and does not require complex training."
Pulmonologist & Intensivist, Palm Beach VAMC
"Gone are the days when respiratory specialists had to adapt equipment and supplies to 'create' solutions. SINODA allows complicated setup scenarios to become so effortless that it reduces the burden on staffing. As a military veteran, we call this a force multiplier. It's a cheap, single-patient solution that should be in every RT's toolbox."
RRT, RPFT, AE-C & Respiratory Specialist Leader
"I have personally witnessed the therapeutic benefits of the SINODA device in acute and critical care. We can simultaneously deliver nebulized meds while maintaining accurate FiO2 in respiratory compromised patients, without having to switch devices. This is truly a great 'all-in-one' device that makes my job easier."
Registered Respiratory Therapist
"I personally have been quite impressed with the SINODA device. The device allows for multiple therapies to be utilized at the same time. It delivers a higher concentration of FiO2 in clinically hypoxic patients while also delivering inhaled medications concurrently. The therapist no longer has to compromise FiO2."
Respiratory Care Specialist
"I was introduced to this product during COVID-19 and was truly impressed by its usage and clinical efficacy. It has the ability to deliver high O2 concentration and deliver inhaled medication at the same time for hypoxic patients. It integrates multiple pieces of standard technology into one product. Highly recommend it!"
Neonatal & Pediatric Respiratory Specialist
"The device is both simple, with minimal moving parts, and versatile in that it can be used with a wide variety of devices used in both adult and pediatric populations. It is likely that this device will become standard equipment in all settings where nebulized medications are used with patients who have moderate and severe respiratory disease."
Board Certified Internal Medicine, Pulmonary Disease & Critical Care
Our entire clinical product catalog is constructed using medical-grade Marlex KN226 Low-Density Polyethylene. Independently verified for patient-contact safety, eliminating volatile compounds, chemical dyes, or allergen exposures.
Contains zero metal or magnetic components, allowing clinicians to run diagnostic MRIs without removing critical airway support.
Geneva Laboratories trials confirm Cytotoxicity Grade 0 (no reactivity) and zero guinea pig dermal sensitization for patient contact.
Minimizes cross-contamination and nosocomial ICU infections. Easy to use, discard, and restock efficiently.
Physical slots dynamically expand and contract to adapt to bodily and room temperature shifts, helping prevent tight lockages.
Critical Care Solutions integrates multiple medical procedures into unified, safety-first systems, resulting in lower plastic waste, lower direct expenses, and massive nursing hours savings.
Watch animated CAD blueprints, bedside configurations, and clinical walkthroughs. Explore downloadable marketing slide decks and patent publications.
Watch the CAD animation illustrating how lighter medical gases remain near the airway while carbon dioxide settles and exits through the bottom one-way valve.
Access official R&D presentation slide decks, physician recommendation letters, biocompatibility laboratory trials, and quality management accreditations.
Please submit the secure B2B request form below to evaluate sample kits for clinical trials or to request credentialed access to the corporate investor deal room.